Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2008, Vol. 28 Issue (10): 39-42    DOI:
    
Construction and expression of fusion domains derived from HIV-1 gp160 and immunogenicity analysis of its purified protein
Download: HTML   PDF(455KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Human immunodeficiency virus (HIV) is the etiologic agent of AIDS.Immunogenic epitopes of HIV resides on virus-encoded envelope glycoproteins. To prepare HIV-1 gp160 protein and used it for clinical diagnosis, three gene fragments of HIV-1 env containing highly immunogenic epitopes were amplified by PCR from plasmid of HIV-1 HXB2. The resulting PCR products were linked and cloned into a prokaryotic expression vector pET28a(+) and the accuracy of the inserted fragments was identified by sequencing. To express the HIV-1 gp160 fusion epitopes in E. coli cells and identify fusion protein, the induced protein was checked with SDS-PAGE and Western Blot (WB). The identified HIV positive serum samples were tested by Western Blot (WB) to analysis immunogenicity of the purified protein. The length of the chimeric fragment derived from HIV-1 gp160 was 969bp, and encoded 37kDa amino acid residues. Procaryotic expression plasmid was constructed successfully which can highly effectively express gp160 fusion protein. Recombinant fusion protein was expressed in Eserichia coli BL21(DE3) as an insoluble protein. Procaryotic expression plasmid which can highly effectively express gp160 fusion protein was constructed successfully. The founding and subjects were provided for the research of diagnosis kit.



Key wordsHIV-1gp160      fusion gene      procaryotic expression      immunogenicity      western blot     
Received: 07 March 2008      Published: 25 October 2008
ZTFLH:  Q786  
Cite this article:

. Construction and expression of fusion domains derived from HIV-1 gp160 and immunogenicity analysis of its purified protein. China Biotechnology, 2008, 28(10): 39-42.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2008/V28/I10/39

[1] CEN Qian-hong,GAO Tong,REN Yi,LEI Han. Recombinant Saccharomyces cerevisiae Expressing Helicobacter pylori VacA Protein and Its Immunogenicity Analysis[J]. China Biotechnology, 2020, 40(5): 15-21.
[2] QI Jia-long, GAO Rui-yu, JIN Shu-mei, GAO Fu-lan, YANG Xu, MA Yan-bing, LIU Cun-bao. Expression and Identification of Varicella-Zoster Virus Glycoprotein E and Immunogenicity Assay[J]. China Biotechnology, 2019, 39(8): 17-24.
[3] Li DU,Xiao-zhi LIU,Jian GAO,Zhi-ming WANG. Research Progress on Immunogenicity Evaluation of Antibodies[J]. China Biotechnology, 2018, 38(2): 89-94.
[4] Jian-rong WU,Xing-qiao PENG,Xiao-bei ZHAN. Advance in Application of Polysialic Acid,a Non-GAGs, Non-immunogenic Biomaterial[J]. China Biotechnology, 2017, 37(12): 96-102.
[5] HAN Han, BAO Dan-qi, YANG Fei-yun, LIU Kun, YANG Tian-rui, YANG Qi, LI Guo-jing, WANG Rui-gang. The Cloning and Function Analysis in Flavonoid Pathway of CiCHIL from Caragana intermedia[J]. China Biotechnology, 2016, 36(9): 11-20.
[6] WANG Jing, XIA Wen-yue, PAN Xiao-xia, ZHAO Bing-xin, TENG Yu-mei, LI Chuan-yin, YANG Xiao-zhou, WEN Yu-ling, CHEN Yuan-ding. Immunological Activity of a Chimeric Protein Carrying an Epitope of Type 2 Poliovirus on the VP6 of Rotavirus as a Vector[J]. China Biotechnology, 2016, 36(8): 1-8.
[7] LIU Pan-rao, ZHOU Xue-chen, ZHU Xue-jiao, BAI Juan, WANG Xian-wei, JIANG Ping. The Soluble Expression of Porcine Circovirus Type 2 Cap Gene in Escherichia coli and Its Immunogenicity in Mice[J]. China Biotechnology, 2016, 36(4): 50-56.
[8] LIAO He-bin, LIU Ma-feng, CHENG An-chun. The Assessment of RecA Acted as an Internal Reference Protein in R. anatipestifer[J]. China Biotechnology, 2015, 35(6): 26-31.
[9] YANG Shuo, HAO Yu-jie, LAN Jin-ping, WEI Han-fu, WEI Jian, RONG Rui-juan, WU Peng-cheng, LIU Guo-zhen, YIN Chang-cheng, LI Li-yun. HPT Protein Detection and Expression Pattern in Transgenic Rice[J]. China Biotechnology, 2015, 35(6): 61-67.
[10] LI Duo, YANG LI-juan, ZHAO Yu-jiao, PAN Yue, CHEN Jun-ying, FU Juan-juan, HUANG Xing-wei, QUE Li-juan, SUN Qiang-ming. Clone, Expression and Immunological Analysis of Type Ⅱ Dengue Virus NS1 Protein[J]. China Biotechnology, 2014, 34(9): 4-8.
[11] PANG Shi-feng, JIANG Chao, LI Wen-rong, FENG Zhi-guo, LIU Min, CHU Sheng-hui, LI Xiao-kun, ZHENG Ke-qin. Cloning of Soybean Oleosin and EGF Fusion Gene and Expression in Safflower Seeds[J]. China Biotechnology, 2014, 34(4): 71-77.
[12] GUO Li-li, OU Xia, MI Kai, SUN Mao-sheng, LI Hong-jun. Expression of Enterovirus 71 VLP in Baculovirus System and Evaluation of Its Immunogenicity[J]. China Biotechnology, 2013, 33(1): 8-13.
[13] SUN Ying, ZHANG Ling-xia, WU Xue-qiong, DONG En-jun. The Study On Construction, Immunogenicity and Protection Against Mycobacterium tuberculosis ofmpt64-recombinant BCG Vaccine[J]. China Biotechnology, 2011, 31(7): 14-19.
[14] WEI Lin, QIU Fei, DIAO Yong. Macromolecule Modified Adenovirus as Vector for Gene Therapy[J]. China Biotechnology, 2011, 31(06): 111-115.
[15] ZHU Xiao-li, WANG Tong-wen. The Influence of Glutaraldehyde Polymerization on Immunological Properties of Porcine Hemoglobin, Bovine Hemoglobin and Human Hemoglobin[J]. China Biotechnology, 2011, 31(06): 12-17.